# CFTR Modulators and Gastrointestinal Complications

> **NCT05253859** · — · COMPLETED · sponsor: **Nottingham University Hospitals NHS Trust** · enrollment: 47023 (actual)

## Conditions studied

- Cystic Fibrosis
- Gastrointestinal System Disease
- Distal Intestinal Obstruction Syndrome
- Pancreatic Enzyme Abnormality
- Pancreatic Disease
- Lung Diseases
- Digestive System Disease

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT05253859
- **Lead sponsor:** Nottingham University Hospitals NHS Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-01
- **Primary completion:** 2024-02-10
- **Final completion:** 2024-02-10
- **Target enrollment:** 47023 (ACTUAL)
- **Last updated:** 2024-07-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05253859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05253859, "CFTR Modulators and Gastrointestinal Complications". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT05253859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*